Cannabis Policy: Legalization, Impact, and the Influence of the Late Mark Kleiman
(Crime, Justice, and Drugs)
*Names in bold indicate Presenter
Since 2012, ten states and the District of Columbia have passed ballot initiatives legalizing recreational cannabis. While one-quarter of the U.S. population now resides in states with legal recreational regimes, residents’ access to cannabis will depend on a diverse set of state and local policies; so too, will the impact of recreational cannabis on public health and safety. This panel, through the presentation of three papers, evaluates the role of federal, state, and local regulatory choices on the development of the recreational cannabis markets based on evidence from three early adopter states. As jurisdictions consider new cannabis regulatory structures, they have limited evidence about the impact of the drug’s availability on health and safety. Following the paper presentations, a celebration will be held of Mark Kleiman's work and the legacy he leaves on the field. Mark Kleiman, an inspirational figure in the fields of drug policy and criminal justice, died in July 2019 at the age of 68. As evidenced by the extraordinary outpouring of tributes to him in the NY Times, Washington Post and elsewhere, he made contributions at many levels; scholarship, programmatic design and public advocacy. Mark was a mainstay of the drugs, crime and justice panels at APPAM over three decades. This session will allow a number of Mark’s friends and colleagues to offer tribute to his life and work.
Causes & Consequences of the Cannabis Price Declines in Washington State - Sam Hampsher, BOTEC Analysis; Clarissa Manning, BOTEC Analysis -
Local Policy Influence on Recreational Cannabis Market Activity: Evidence from Oregon and Washington - Greg Midgette, University of Maryland; Julia Dilley, Oregon Health Authority
The Development of New Measures of Cannabis Market Exposure: A Case Study in Colorado - Rosalie Pacula, Pardee RAND Graduate School